Results 21 to 30 of about 7,902 (191)
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
Mark GreathouseSouth Hills Cardiology Associates of Pittsburgh, Pittsburgh, PA, USAAbstract: In most patients with hypertension, especially Stage 2 hypertension, adequate control of blood pressure (BP) is only achieved with combination drug therapy. When
Mark Greathouse
doaj +1 more source
Olmesartan‐Associated Enteropathy: An Uncommon Cause of Chronic Diarrhea
Olmesartan‐associated sprue‐like enteropathy is an uncommon side effect and should be considered as a differential diagnosis in patients who are on Olmesartan and presenting with chronic unexplained diarrhea.
Ahmed Sayedahmed +5 more
doaj +2 more sources
Olmesartan/amlodipine: a review of its use in the management of hypertension
R KreutzInstitute of Clinical Pharmacology and Toxicology, Charité, Universtitätsmedizin – Berlin, GermanyAbstract: Combination therapy is an effective strategy to increase antihypertensive efficacy in those patients with poor blood ...
Kreutz R
doaj +2 more sources
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN [PDF]
The paper presents the results of experimental studies and clinical trials which demonstrate nephroprotective effects of olmesartan.
V. V. Fomin
doaj +2 more sources
Improvement of Erectile Function After Switching From Valsartan to Olmesartan Within a Fixed‐Dose Antihypertensive Combination: A Case Report [PDF]
ABSTRACT Intra‐class differences may exist between ARBs regarding tissue‐specific outcomes. In this case, valsartan was probably associated with erectile dysfunction (Naranjo score 7). Switching to olmesartan was followed by resolutions of symptoms. An intra‐class switch may be considered in selected patients with suspected drug‐associated erectile ...
Ćurković M, Ćurković N.
europepmc +2 more sources
Background/Aims: Blockage of the renin-angiotensin II system (RAS) prevents or delays albuminuria in diabetic patients. The aim of this study was to investigate the inhibitory mechanism of the angiotensin receptor blocker olmesartan on albuminuria in a ...
Junhui Gu +14 more
doaj +1 more source
Olmesartan-Associated Enteropathy [PDF]
Olmesartan, an angiotensin-receptor blocker frequently prescribed for hypertension, has been commercially available since 2002. In 2012, olmesartan-associated enteropathy was described, and the Food and Drug Administration now requires a black-box warning for olmesartan regarding severe diarrhea.
Vivian S, Ebrahim +5 more
openaire +2 more sources
Low dose aspirin is routinely taken with antihypertensive drugs such as olmesartan and metoprolol to avoid the cardiovascular and renal outcomes associated with high blood pressure. The first spectrofluorimetric method for quantifying aspirin, olmesartan,
Ali Alqahtani +3 more
doaj +1 more source
Der siebente Angiotensin-II-Rezeptorantagonist, nahe verwandt mit Losartan und ähnlich wirksam wie andere Sartane.
openaire +1 more source
Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan
Olmesartan-induced enteropathy is an underreported phenomenon, first described in 2012. While olmesartan’s antihypertensive properties were confirmed early on, its association with a sprue-like enteropathy was subsequently noted.
Mihir Odak MD +4 more
doaj +1 more source

